THINK Surgical Appoints Rick McDowell as Vice President of Sales
THINK Surgical has announced that Rick McDowell has joined the company as Vice President of Sales. In this role, McDowell will report to Chris Marrus, Executive Vice President, and will lead THINK Surgical’s national sales organization, driving market strategy and growth as the company continues to scale its commercial operations.
McDowell brings more than 20 years of experience in medical device commercialization, clinical strategy, and capital sales, with a career spent building and leading high-performing sales, clinical, and marketing teams across the surgical robotics industry. McDowell joins THINK Surgical from Gigly, where he served as Chief Commercial Officer, directing enterprise-wide commercial strategy, brand positioning, and go-to-market execution. Prior to Gigly, McDowell led capital sales for Procept BioRobotics across the North Central United States and spent over a decade at Stryker Robotics/Orthopaedics, most recently as Area Sales Director for the Southeast region. McDowell began his career in robotic surgery at MAKO Surgical, where he held progressively senior sales leadership roles over more than four years, including Director of Clinical Sales.
Across his career, McDowell has generated over half a billion dollars in lifetime capital and disposable sales. He is the recipient of the Tim Scannell Legacy Award from Stryker for Contributions Over Time in 2022 and was named Stryker Robotics/Orthopaedics Area Sales Director of the Year in 2016. McDowell is recognized as an expert in concept selling, hospital procurement, and long-cycle capital equipment negotiations, and has played an instrumental role in the launch and market expansion of some of the most disruptive technologies in orthopedic robotics.
Rick McDowell said he is excited to join THINK Surgical at such a pivotal point in the company’s growth. McDowell noted that THINK Surgical has built something special in the orthopedic robotics space, and that he looks forward to working alongside Marrus and the broader team to accelerate commercial momentum and bring the company’s technology to more surgeons and patients.
